RT @CMAJ: Effectiveness of nirmatrelvir–ritonavir at the population level: Among Ontarians who tested positive for SARS-CoV-2, use of nirma…
Seems pretty definitive....
RT @CMAJ: Effectiveness of nirmatrelvir–ritonavir at the population level: Among Ontarians who tested positive for SARS-CoV-2, use of nirma…
Effectiveness of nirmatrelvir–ritonavir at the population level: Among Ontarians who tested positive for SARS-CoV-2, use of nirmatrelvir–ritonavir reduced hospital admission or death compared to nonuse ➡️ https://t.co/CSYVE70iCO @DrKevinSchwartz @BRxAD @Mi
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
Paxlovid should be much more widely available, as should testing. Come on Ontario! #covid
Does it mean no need for vaccination because we have paxlovid?
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
Paxlovid is hardly used in the Netherlands (https://t.co/rDxYvXHMF1). This shows the contempt for vulnerable human lives in this country, especially among politicians and policy makers. https://t.co/1tOmZMP3Da #COVID19NL #Rutte #VanDissel #Kuipers #Sacrif
RT @DrFahadRazak: Great new Canadian study showing real world benefit of Paxlovid in the Omicron era and among vaccinated individuals - Giv…
RT @DrFahadRazak: Great new Canadian study showing real world benefit of Paxlovid in the Omicron era and among vaccinated individuals - Giv…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @FarmaMadridAP: (cmaj) Evaluación basada en la población de la eficacia de nirmatrelvir-ritonavir para reducir los ingresos hospitalario…
Careful population based study in Canada concludes Paxlovid works in real world. Prevents hospitalizations and deaths.
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @AlisonNolan9: @MeetJess Here's the original paper. https://t.co/mni8tM5x7Q
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
@MeetJess Here's the original paper. https://t.co/mni8tM5x7Q
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @IrfanDhalla: This figure, in a new @CMAJ paper by @DrKevinSchwartz et al., provides real-world evidence re: usefulness of Paxlovid in p…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @dragonfly_jenny: Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for wors…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
Yet, so few people with #COVID19 in #Saskatchewan qualify for #Paxlovid, even if they’re at an increased risk for worse outcomes. @SaskHealth will studies like this have an impact on policy? Is this a government decision, or a medical decision? Who am I ev
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
RT @EricTopol: New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point…
New Ontario, Canada report of Paxlovid effectiveness shows 44% reduction of hospitalizations, 51% reduction of deaths (point estimates) without being significantly affected by age (67% age 70+) or vaccination status https://t.co/b3AQq8tmax @CMAJ https://t.
記事『COVID-19による入院と死亡率を減らすためのニルマトレルビル-リトナビル(Paxlovid)の有効性の人口ベースの評価』 カナダのオンタリオ州での、オミクロン支配下(2022年4月4日~8月31日)でのPaxlovidの有効性の調査。 結論的にはオミクロンにもPaxlovidは有効、と。 https://t.co/Cbtl18ql4t
RT @IrfanDhalla: This figure, in a new @CMAJ paper by @DrKevinSchwartz et al., provides real-world evidence re: usefulness of Paxlovid in p…
RT @DrFahadRazak: Great new Canadian study showing real world benefit of Paxlovid in the Omicron era and among vaccinated individuals - Giv…
RT @IrfanDhalla: This figure, in a new @CMAJ paper by @DrKevinSchwartz et al., provides real-world evidence re: usefulness of Paxlovid in p…
Canada's #TestingDebacle still paying dividends.
RT @DrFahadRazak: Great new Canadian study showing real world benefit of Paxlovid in the Omicron era and among vaccinated individuals - Giv…
@VPrasadMDMPH @JasonConnorPhD @ClementLeeMD @JLimHospMD Canada also jumping on the confounded data set mining. Interestingly they do note EPIC-HR and EPIC-SR so i'll give them some credit. Their efforts would be better spent helping get the PANORAMIC data
Great new Canadian study showing real world benefit of Paxlovid in the Omicron era and among vaccinated individuals - Given no RCTs forthcoming, this makes the case for continued use of Paxlovid for high risk outpatients. @DrKevinSchwartz @KevinAnBrown h
This figure, in a new @CMAJ paper by @DrKevinSchwartz et al., provides real-world evidence re: usefulness of Paxlovid in people with Covid. One of the findings that struck me reading the paper is that only ~5% of Ontarians with Covid are getting the drug.
📢 JUST PUBLISHED 📢 #UofTEPIC member @DrKevinSchwartz is the lead author on a new population cohort-based study in @CMAJ looking at the effectiveness of Paxlovid for reducing hospital admissions and mortality from COVID-19. https://t.co/UR07NTI78i
"Population-based evaluation of the effectiveness of nirmatrelvir–ritonavir for reducing hospital admissions and mortality from COVID-19." Publié ce jour dans le @CMAJ. #MedTwitter #IDTwitter #COVID19 https://t.co/C9sQdVfV5e
One more time! Myth of “real world evidence” keeps going strong “Magic” of randomization remains too poorly understood and support - this is very unfortunate New #paxlovid data: https://t.co/iSsW3tJSXn #EBM #RCT #RWE https://t.co/4irZIf1GPV
RT @benryanwriter: A new study finds that Paxlovid substantially reduced the risk of hospitalization and death among those at substantial r…
Paxlovid substantially reduced risk of hospitalization, death during Omicron wave @CMAJ @CMAJ https://t.co/ZvXVQUzczb https://t.co/t7ZF2iHyUf
(cmaj) Evaluación basada en la población de la eficacia de nirmatrelvir-ritonavir para reducir los ingresos hospitalarios y la mortalidad por COVID-19 https://t.co/VfXtCWCDrZ
Population-based evaluation of the effectiveness of nirmatrelvir–ritonavir for reducing hospital admissions and mortality from COVID-19 | CMAJ 👇👇 https://t.co/jmiemHxznV